EUVIMEDEUVIMED entdecken
Multizentrische Studie

Steroid pulse therapy in idiopathic nephrotic syndrome in the era of modern immunosuppressive treatment—still up to date?

Cyrielle Parmentier, Solene Victor, Claire Dossier, Jean Daniel Delbet, Julien Hogan, Antoine Mouche, Olivia Boyer, Tim Ulinski

Pediatric Nephrology · 2025

DOI: 10.1007/s00467-024-06535-x ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Nephrology, 2025. Verfasst von Cyrielle Parmentier und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nephrology Unit - Trousseau Hospital-APHP, ORIGYNE and Sorbonne University-Paris, 26 Av du Docteur Arnold Netter, 75012, Paris, France. Hauptthemen laut MEDLINE: Nephrotic Syndrome, Immunosuppressive Agents, Remission Induction. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intravenous steroid pulses (SP) are successfully used for the treatment of patients with idiopathic nephrotic syndrome (INS) resistant to oral prednisone. METHODS: We performed a retrospective analysis of all patients in the three pediatric nephrology centers of the Paris region from 2002 to 2022 who were resistant to a 30-day course of oral prednisone and who received SP for their first INS flare and analyzed their disease course over 4 years. RESULTS: Forty-seven patients (17 girls), median age 3.4 years, were analyzed. Of them, 68% reached remission within 7 days of SP. No significant short-term side effects were noted. Half of the patients started immunosuppressive treatment immediately after their first remission and 62% of them relapsed at least once, whereas all the patients who did not receive immunosuppressive treatment since their first remission relapsed. Among the SP-sensitive patients, 75% needed calcineurin inhibitor (CNI) or B-cell depletion during their disease course to achieve stable remission. Forty-two percent of the whole cohort received B-cell-depleting agents. Among the 15 SP-resistant patients, all received CNI. Twelve/fifteen patients reached remission. After 4 years, 68% among the SP-sensitive patients and 87% of SP-resistant patients still had an active disease. CONCLUSIONS: SP are helpful to obtain rapid remission in pediatric INS patients resistant to oral steroids. However, as most SP-sensitive patients need immunosuppressive drugs, mainly CNI and B-cell-depleting agents it could be interesting to discuss the possibility to start CNI directly after the 30-day course of prednisone instead of SP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrotic SyndromeImmunosuppressive AgentsRemission InductionHumansFemaleMaleRetrospective StudiesChildChild, PreschoolTreatment OutcomePrednisonePulse Therapy, DrugAdolescentInfantGlucocorticoidsCalcineurin InhibitorsRecurrenceDrug ResistanceParis

Stichwörter der Autor:innen

B-cell depletionCalcineurin inhibitors (CNI)Idiopathic nephrotic syndrome (INS)ImmunosuppressionLong-term disease activitySteroid pulses

Substanzen

Immunosuppressive AgentsPrednisoneGlucocorticoidsCalcineurin Inhibitors

Autor:innen und Institutionen

  • Pediatric Nephrology Unit - Trousseau Hospital-APHP, ORIGYNE and Sorbonne University-Paris, 26 Av du Docteur Arnold Netter, 75012, Paris, France.
  • Pediatric Nephrology Unit - Robert Debré Hospital-APHP, University-Paris Cité, Paris, France.
  • Pediatric Nephrology Unit - Necker Enfants Malades-APHP, University-Paris Cité, Paris, France.
  • Pediatric Nephrology Unit - Trousseau Hospital-APHP, ORIGYNE and Sorbonne University-Paris, 26 Av du Docteur Arnold Netter, 75012, Paris, France. tim.ulinski@aphp.fr.

Zitieren

APA

Parmentier, C., Victor, S., Dossier, C., Delbet, J. D., Hogan, J., Mouche, A., Boyer, O., & Ulinski, T. (2025). Steroid pulse therapy in idiopathic nephrotic syndrome in the era of modern immunosuppressive treatment—still up to date?. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06535-x

Vancouver

Parmentier C, Victor S, Dossier C, Delbet JD, Hogan J, Mouche A, et al. Steroid pulse therapy in idiopathic nephrotic syndrome in the era of modern immunosuppressive treatment—still up to date?. Pediatric Nephrology. 2025. doi:10.1007/s00467-024-06535-x

BibTeX
@article{Parmentier2025,
  author = {Parmentier, Cyrielle and Victor, Solene and Dossier, Claire and Delbet, Jean Daniel and Hogan, Julien and Mouche, Antoine and Boyer, Olivia and Ulinski, Tim},
  title = {Steroid pulse therapy in idiopathic nephrotic syndrome in the era of modern immunosuppressive treatment—still up to date?},
  journal = {Pediatric Nephrology},
  year = {2025},
  doi = {10.1007/s00467-024-06535-x}
}
Kostenlos starten →